Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IVVD
#2829
Invivyd, Inc. Common Stock
1.6
9
-1.17%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.17%
Monthly Change
-17.56%
6 month change
+74.23%
Year Change
+40.83%
Previous Close
1.7
1
Open
1.6
9
Bid
Ask
Low
1.6
9
High
1.6
9
Volume
53
Markets
US Stock Market
Healthcare
IVVD
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
TTM
Cash from operating activities
184.74 M
219.99 M
173.16 M
170.49 M
80.29 M
Cash from investing activities
50.71 M
230.67 M
280.68 M
140 K
150 K
Cash from financing activities
662.68 M
506 K
1.04 M
39.33 M
58.53 M
Free cash flow
184.65 M
218.28 M
172.55 M
170.35 M
80.14 M
News
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Invivyd (IVVD) CHRO Green sells $63k in stock after option exercise
Invivyd CSO Allen sells shares worth $58,600
Halozyme Therapeutics (HALO) Reports Q4 Loss, Tops Revenue Estimates
H.C. Wainwright reiterates Buy rating on Invivyd stock amid FDA feedback
Invivyd receives FDA feedback on COVID antibody vs mRNA vaccine trial
H.C. Wainwright reaffirms Buy rating on Invivyd stock ahead of key trial data
Invivyd stock rises after partnering with Olympic champion Lindsey Vonn
Invivyd partners with ski champion Lindsey Vonn on antibody education
Invivyd stock maintains Buy rating at BTIG on Long COVID treatment potential
Invivyd to begin phase 2 trial of antibody therapy for long COVID